about
Treatment Modalities for AcneTopical acne treatments in Europe and the issue of antimicrobial resistance.Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet.Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in InfantsErlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectivenessPrevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka.Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.Macular lymphocytic arteritis: Clinical-pathologic correlation of a rare vasculitis.Current bioanalytical methods for pharmacokinetic studies of drugs used in neglected tropical diseases.Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical Modification.An Update on Medical Treatment Options for Hidradenitis Suppurativa.Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy.Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity.Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.Treatment of antiviral-resistant recurrent erythema multiforme with dapsone.Dapsone-associated fixed drug eruption.Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches.Dapsone and azole interactions: A clinical perspective.Synchronizing Pharmacotherapy in Acne with Review of Clinical Care.A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa (Regimen with Metformin, Liraglutide, Dapsone, and Finasteride): A Case Report.Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar.Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.Remission of refractory metastatic Crohn's disease achieved with dapsone.Dapsone for topical use in extemporaneous preparations.Dapson für die topische Therapie in magistralen Rezepturen.S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).Supramolecular Organization of Nonstoichiometric Drug Hydrates: Dapsone.Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation.Dapsone-induced Methemoglobinemia in a Child with End-stage Renal Disease: A Brief Review.Molecular Level Understanding of the Reversible Phase Transformation between Forms III and II of DapsoneSynthesis and X-Ray Structure of (1Z,2Z)-1,2-Bis(2-(phenylsulfonyl)-1-(4-tolyl)ethylidene)hydrazine
P2860
Q26741233-1B9F5678-8414-4157-A2B1-0748E20C42D8Q34462485-87CF421B-C8B6-44D2-87AD-B4525CE97221Q35015547-EC6EE3CC-9AB9-4D5B-8FF5-C051BA81C6A9Q35850290-18CE937E-9E92-4ED5-8EEF-5F468EE9E47BQ36234132-04CDFA94-A869-4E67-A429-F7600F7D09BBQ36267671-DDE104D7-F0EA-445A-9554-C2916D6025D9Q37364920-1390DBD3-D1A9-48DE-B32C-4A505F4D1EA5Q37698639-EC7AE8F8-D4EF-4894-AA93-99E597F63AA8Q38235444-0EDA23F4-501A-46CA-A756-F2EFD3C796E4Q38602644-A97F9CA0-62D8-4DD5-9B65-A36668032D44Q38667207-A055EC05-862A-474C-B9A5-7CFC6FE4A622Q38766862-8F4C5217-FD79-46F0-8C27-CB023F05ECBCQ38811369-A2297480-CDDC-4996-9B3A-FBDECA82E902Q38891976-2080A8D4-195A-4221-AB0E-6AF0A315F148Q39004668-CBC445AD-A145-4BB8-9AFE-E4081E5F6562Q39012469-396C89A3-B9BA-47E7-AC7C-468EE4AF4F7DQ39256996-8C2F4B61-FD9C-4408-9380-2F6BF4539AEBQ39426072-1F1361B9-BEEA-4CD0-98A2-1CF62E43CEAAQ39450909-893B12D9-308F-45D7-8E62-FFDCF4C4696FQ41129273-4C5A2266-400B-47D0-9C20-A2AFD172C705Q41488077-DD7146CB-E395-4008-A2A7-2F9E40120403Q42332323-DC47C8A3-7E13-4F18-B474-5D33DA67399CQ43071772-27C50B15-E0E8-4959-A22F-1C688A39D86FQ48273975-4F206DEB-05C5-43F0-B93E-FBF1DE0D4469Q49561589-49E84648-1EDB-43D0-901E-4F6E50183BF7Q50122698-E616F928-68A2-4DC3-ACA0-A8027D3717FEQ52836583-C28C2B94-FA81-46F8-98B4-44A8A0C16A61Q53438493-50BF7E4D-FA32-4E75-BD4E-D7FA9D294781Q55004459-1070F66A-5715-4785-91C8-586EA9965A2CQ55281824-28805195-1FA8-4C69-BAAC-7FCE8D928B0EQ57864019-642ECF68-749C-4C35-863D-7F453B45B58AQ59054975-4A349497-88CC-4FE2-99DB-77FEFDD81812
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dapsone in dermatology and beyond
@ast
Dapsone in dermatology and beyond
@en
Dapsone in dermatology and beyond
@nl
type
label
Dapsone in dermatology and beyond
@ast
Dapsone in dermatology and beyond
@en
Dapsone in dermatology and beyond
@nl
prefLabel
Dapsone in dermatology and beyond
@ast
Dapsone in dermatology and beyond
@en
Dapsone in dermatology and beyond
@nl
P2860
P921
P1476
Dapsone in dermatology and beyond
@en
P2093
Christian Blasum
Gottfried Wozel
P2860
P2888
P304
P356
10.1007/S00403-013-1409-7
P577
2013-12-06T00:00:00Z
2014-03-01T00:00:00Z
P5875
P6179
1020243576